Updated Estimates of Patients With Oropharyngeal Cancer in the US
In this cross-sectional study of OPC, the incidence of OPC in the US increased rapidly from 2006 to 2021 among male individuals, particularly among those aged 65 years and older. Although the distribution of treatment was similar through the assessed years, increased limited-duration prevalence and higher than previously reported survival were observed. A smaller proportion of patients with localized stage OPC were treated, especially among those aged 65 years and older, suggesting that further research is needed for optimal patient outcomes.
Authors
- Jennifer R. Cracchiolo (ORCID: https://orcid.org/0000-0003-4496-906X)
- Kaveh Zakeri (ORCID: https://orcid.org/0000-0003-3921-480X)
- Nadeem Riaz (ORCID: https://orcid.org/0000-0001-9873-5862)
- Yao Yu (ORCID: https://orcid.org/0000-0002-2814-4482)
- Jennifer Ma (ORCID: https://orcid.org/0000-0001-8133-2282)
- Lara Ann Dunn (ORCID: https://orcid.org/0000-0001-5318-2571)
- Edward Christopher Dee (ORCID: https://orcid.org/0000-0001-6119-0889)
- Teeradon Treechairusame (ORCID: https://orcid.org/0000-0002-2731-9500)
- Eric Jeffrey Sherman (ORCID: https://orcid.org/0000-0002-4960-4783)
- Marc A. Cohen (ORCID: https://orcid.org/0000-0002-6104-7967)
- Irini Youssef (ORCID: https://orcid.org/0000-0001-5589-0782)
- Richard J. Wong (ORCID: https://orcid.org/0000-0001-6259-7314)
- Achraf A. Shamseddine (ORCID: https://orcid.org/0000-0003-3686-5850)
- Nancy Y. Lee
- Jung Julie Kang (ORCID: https://orcid.org/0000-0001-9773-5481)
- Anna Lee (ORCID: https://orcid.org/0000-0002-9114-1815)
- Caineng Cao
- Winston Wong
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- SUNY Downstate Health Sciences University (US)
- Yale University (US)
- Zhejiang Cancer Hospital (CN)
- Hangzhou Cancer Hospital (CN)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-10-24
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.39258
- Citations
- 2
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.70
Funders
- Prostate Cancer Foundation
- Pfizer
- AstraZeneca
- Regeneron Pharmaceuticals
- Eisai
- National Institutes of Health
- National Cancer Institute